Santhera Pharmaceuticals (0QN1.LSE) Q2 2025 Earnings

Apr 29Confirmed
Q2 2023
Q2 2024
Q3 2024
Q2 2025
-1.9
-1.26
-0.63
-0

Details

Expected EPS
N/A
Actual EPS
-1.895292417348
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Santhera Pharmaceuticals⁩ (⁦0QN1.LSE⁩) has reported earnings of ⁦-1.895292417348⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts